연구

연구업적

최근 5년 연구업적 현황
연도 2023년 2022년 2021년 2020년 2019년
SCI 논문
발표편수
책임 173편 163편 184편 135편 144편
공동 120편 115편 136편 168편 167편
합계 293편 278편 320편 303편 311편
1331. Cotinine-conjugated aptamer/anti-cotinine antibody complexes as a novel affinity unit for use in biological assays.
Park S, Hwang D, Chung J.
Exp Mol Med. 2012 Sep 30;44(9):554-61. Link
1330. Nanoparticles modified by encapsulation of ligands with a long alkyl chain to affect multispecific and multimodal imaging.
Lee YK, Jeong JM, Hoigebazar L, Yang BY, Lee YS, Lee BC, Youn H, Lee DS, Chung JK, Lee MC.
J Nucl Med. 2012 Sep;53(9):1462-70. Link
1329. Development of a bifunctional chelating agent containing isothiocyanate residue for one step F-18 labeling of peptides and application for RGD labeling.
Shetty D, Jeong JM, Kim YJ, Lee JY, Hoigebazar L, Lee YS, Lee DS, Chung JK.
Bioorg Med Chem. 2012 Oct 1;20(19):5941-7. Link
1328. Evaluation of (111)In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging.
Lee JJ, Shetty D, Lee YS, Kim SE, Kim YJ, Hong MK, Son JY, Jeong JM.
Nucl Med Biol. 2012 Apr;39(3):325-33. Link
1327. Syntheses of 2-nitroimidazole derivatives conjugated with 1,4,7-triazacyclononane-N,N'-diacetic acid labeled with F-18 using an aluminum complex method for hypoxia imaging.
Hoigebazar L, Jeong JM, Lee JY, Shetty D, Yang BY, Lee YS, Lee DS, Chung JK, Lee MC.
J Med Chem. 2012 Apr 12;55(7):3155-62. Link
1326. The cAMP signaling system inhibits the repair of γ-ray-induced DNA damage by promoting Epac1-mediated proteasomal degradation of XRCC1 protein in human lung cancer cells.
Cho EA, Juhnn YS.
Biochem Biophys Res Commun. 2012 Jun 1;422(2):256-62. doi: 10.1016/j.bbrc.2012.04.139. Epub 2012 May 1. Link
1325. The Lack of CD34 Expression in Gastrointestinal Stromal Tumors is Related to Cystic Degeneration Following Imatinib Use
Koh Y, Lee HE, Oh DY, Kim JH, Lee SH, Kim SH, Kim DW, Im SA, Kim TY, Heo DS, Kim WH, Bang YJ
Jpn J Clin Oncol. 2012 Nov;42(11):1020-7 Link
1324. Small node-negative (T1b-cN0) invasive hormone receptor-positive breast cancers: is there a subpopulation that might have benefit from adjuvant chemotherapy?
Park YH, Im SA, Cho EY, Choi YL, Lee JE, Nam SJ, Yang JH, Ahn JS, Im YH.
Breast Cancer Res Treat. 2012 May;133(1):247-55 Link
1323. Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy.
Keam B, Im SA, Koh Y, Han SW, Oh DY, Cho N, Kim JH, Han W, Kang KW, Moon WK, Kim TY, Park IA, Noh DY, Chung JK, Bang YJ
Breast Cancer. 2012 Feb 7 Link
1322. The prognostic significance of HER2 positivity for advanced gastric cancer patients undergoing first-line modified FOLFOX-6 regimen.
Kim JW, Im SA, Kim M, Cha Y, Lee KH, Keam B, Kim MA, Han SW, Oh DY, Kim TY, Kim WH, Bang YJ
Anticancer Res. 2012 Apr;32(4):1547-53 Link